| P2093 | author name string | Daniel L Brown | |
| | Jad Ibrahim | |
| | Matthew S Stankowicz | |
| P2860 | cites work | Wide variation in single, daily-dose aminoglycoside pharmacokinetics in patients with burn injuries | Q73206558 |
| | National survey of extended-interval aminoglycoside dosing | Q73560643 |
| | A survey of extended-interval aminoglycoside dosing practices in United States adult cystic fibrosis programs | Q87784244 |
| | Aminoglycosides--50 years on | Q95806228 |
| | Validation and nephrotoxicity of a simplified once-daily aminoglycoside dosing schedule and guidelines for monitoring therapy | Q28379292 |
| | Prediction of creatinine clearance from serum creatinine | Q29615603 |
| | Once daily aminoglycoside therapy. Is it less toxic than multiple daily doses and how should it be monitored? | Q33545113 |
| | The economic impact of once-daily versus conventional administration of gentamicin and tobramycin | Q33573691 |
| | Once-daily dosing of aminoglycoside antibiotics | Q33928699 |
| | Pharmacokinetics of tobramycin in adults with cystic fibrosis: implications for once-daily administration | Q33979054 |
| | Incidence of and significant risk factors for aminoglycoside-associated nephrotoxicity in patients dosed by using individualized pharmacokinetic monitoring | Q34061646 |
| | Determinants of efficacy and toxicity of aminoglycosides | Q34510814 |
| | Pharmacokinetics of gentamicin at traditional versus high doses: implications for once-daily aminoglycoside dosing. | Q35136143 |
| | Suboptimal aminoglycoside dosing in critically ill patients | Q37341556 |
| | Extended-interval once-daily dosing of aminoglycosides in adult and pediatric patients with cystic fibrosis | Q37661512 |
| | Evaluation of four once-daily aminoglycoside dosing nomograms | Q39221496 |
| | Once versus thrice daily gentamicin in patients with serious infections | Q39369365 |
| | Antibiotic pharmacokinetics in cystic fibrosis. Differences and clinical significance | Q39673276 |
| | Experience with a once-daily aminoglycoside program administered to 2,184 adult patients | Q39779327 |
| | Once-daily administration of aminoglycosides | Q40627605 |
| | Once-daily versus thrice-daily dosing of netilmicin in combination with beta-lactam antibiotics as empirical therapy for febrile neutropenic patients | Q40718971 |
| | Once-daily dosing of aminoglycosides: review and recommendations for clinical practice | Q41530531 |
| | Single or multiple daily doses of aminoglycosides: a meta-analysis | Q42145555 |
| | Therapeutic drug monitoring of tobramycin: once-daily versus twice-daily dosage schedules | Q42537036 |
| | Individualized pharmacokinetic monitoring results in less aminoglycoside-associated nephrotoxicity and fewer associated costs | Q43580192 |
| | Comparison of gentamicin dosing regimens using an in-vitro model. | Q43779314 |
| | Once-daily tobramycin in the treatment of adult patients with cystic fibrosis | Q43897091 |
| | Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration | Q44483617 |
| | Once-daily aminoglycoside dosing: impact on requests and costs for therapeutic drug monitoring | Q47832029 |
| | A meta-analysis of the relative efficacy and toxicity of single daily dosing versus multiple daily dosing of aminoglycosides. | Q50509585 |
| | A meta-analysis of extended-interval dosing versus multiple daily dosing of aminoglycosides. | Q50509590 |
| | Aminoglycosides: single or multiple daily dosing? A meta-analysis on efficacy and safety. | Q50522237 |
| | Population analysis of once-daily dosing of gentamicin in patients with neutropenia. | Q50875106 |
| | Population pharmacokinetics of aminoglycosides in critically ill trauma patients on once-daily regimens. | Q52071390 |
| | A multicentric study of netilmicin once daily versus thrice daily in patients with appendicitis and other intra-abdominal infections | Q69522572 |
| | Netilmicin in the treatment of gram-negative bacteremia: single daily versus multiple daily dosage | Q69589550 |
| | Once-daily dosing decreases renal accumulation of gentamicin and netilmicin | Q69936275 |
| | Postantibiotic effects | Q70073524 |
| | Experience of once-daily aminoglycoside dosing using a target area under the concentration-time curve | Q71559681 |
| | Antimicrobial practice. Development of guidelines for gentamicin dosing | Q71876797 |
| | Postantibiotic effect in Pseudomonas aeruginosa following single and multiple aminoglycoside exposures in vitro | Q72196470 |
| | Pharmacodynamic characterization of nephrotoxicity associated with once-daily aminoglycoside | Q73167979 |
| P433 | issue | 16 | |
| P304 | page(s) | 1357-1364 | |
| P577 | publication date | 2015-08-01 | |
| P1433 | published in | American Journal of Health-System Pharmacy | Q15754037 |
| P1476 | title | Once-daily aminoglycoside dosing: An update on current literature | |
| P478 | volume | 72 | |